2017-03-01,FibroGen Reports Fiscal 2016 Financial Results
2017-02-22,FibroGen To Report Fiscal 2016 Financial ResultsÂ on March 1, 2017
2017-02-03,FibroGen Announces Publication Of Pamrevlumab (FG-3019) Clinical Data In Pancreatic Cancer Showing Safety And Improved Survival Outcomes In Combination With Chemotherapy
2017-01-30,7 Things to Watch in Biotech Now
2017-01-30,Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen
2017-01-30,FibroGen's Roxadustat (FG-4592) Meets Primary Endpoints In Two Phase 3 Anemia Studies In China
2017-01-24,Interesting FGEN Put And Call Options For September 15th
2017-01-20,Pamrevlumab Pancreatic Cancer Clinical Data Presented At ASCO 2017 Gastrointestinal Cancers Symposium
2017-01-12,First Week of February 17th Options Trading For FibroGen (FGEN)
2016-12-20,Akebia Funds Late-Stage Studies of Anemia Pill With Partnership for U.S. Commercial Rights
2016-12-12,Facebook, Apple, Starbucks: Doug Kass' Views
2016-12-05,Apple, Starbucks, Cisco: Doug Kass' Views
2016-11-25,Apple Continues to Underperform; the Market Is Resistant: Best of Kass
2016-11-08,FibroGen Reports Financial Results For The Third Quarter Of 2016 And Provides Corporate Update
2016-11-01,FibroGen To Report Third Quarter 2016 Financial Results On November 8, 2016
2016-10-31,FibroGen Completes Enrollment In Roxadustat Phase 3 Studies In China
2016-08-08,FibroGen Reports Financial Results For The Second Quarter Of 2016
2016-08-02,FibroGen To Report Second Quarter 2016 Financial Results On August 8, 2016
2016-07-25,Astellas And FibroGen Announce First Patient Treated In Phase 3 Studies And Positive Phase 2 Results Of Roxadustat In Patients With Chronic Kidney Disease In Japan
2016-07-08,FibroGen Announces Receipt Of $62 Million License Payment From AstraZeneca
2016-06-21,First Week of August 19th Options Trading For FibroGen (FGEN)
2016-06-15,Trade-Ideas: FibroGen (FGEN) Is Today's Weak On High Relative Volume Stock
2016-06-09,FibroGen Announces Initiation By Astellas Of Phase 3 Clinical Study In Japan Of Roxadustat/ASP1517 For The Treatment Of Anemia Of Chronic Kidney Disease Triggering $10.0 Million Milestone Payment
2016-06-06,FibroGen To Present At The Goldman Sachs 37th Annual Global Healthcare Conference
2016-05-09,FibroGen Reports Financial Results For The First Quarter Of 2016
2016-05-02,FibroGen To Report First Quarter 2016 Financial Results On May 9, 2016
2016-04-20,Promising Phase 2 Data Show Roxadustat Corrected Anemia In Chronic Kidney Disease Patients Before Intervention With Dialysis
2016-04-07,Weak On High Volume: FibroGen (FGEN)
2016-03-21,FibroGen (FGEN) Flagged As Strong On High Volume
2016-03-11,FibroGen Announces Publication Of Phase 2 Study Results Supporting The Potential Of FG-3019 To Treat Patients With Idiopathic Pulmonary Fibrosis
2016-02-29,FibroGen Announces Fiscal 2015 Financial Results
2016-02-19,FibroGen To Report Fourth Quarter And Full Year 2015 Financial Results On February 29, 2016
2016-02-16,FibroGen Publishes Encouraging Phase 2 Anemia Data Demonstrating Roxadustat's Ability To Maintain Hemoglobin Levels In Patients With Chronic Kidney Disease
2016-02-04,FibroGen (FGEN) Stock: Weak On High Volume Today
2016-01-28,FibroGen (FGEN) Is Weak On High Volume Today
2016-01-27,FibroGen Announces Early Phase 2 Data From A Clinical Study Of FG-3019 In Combination With Chemotherapy As Neoadjuvant In Locally Advanced, Unresectable Pancreatic Cancer
2016-01-06,FibroGen Enrolls First Patients In Phase 2 Clinical Study Of Anti-Fibrotic Drug Candidate FG-3019 For The Treatment Of Duchenne Muscular Dystrophy
2015-12-18,Insider Trading Alert - FGEN, RSPP And CNBKA Traded By Insiders
2015-12-15,Ratings Changes Today
2015-12-14,Akebia Secures Asian Partner and Funding for Anemia Pill
2015-11-12,FibroGen Announces Third Quarter 2015 Financial Results
2015-11-05,FibroGen To Report Third Quarter 2015 Financial Results On November 12, 2015
2015-11-03,FibroGen To Present Roxadustat Clinical Data In Four Presentations At American Society Of Nephrology - Kidney Week 2015
2015-10-29,FibroGen Appoints Jeffrey Edwards To Board Of Directors
2015-10-22,Phase 2 Data For Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Show Anemia Correction In Incident Dialysis Chronic Kidney Disease Patients Regardless Of Iron Repletion Status, Iron Supplementation Regimen, Or Dialysis Modality
2015-10-02,Biotech Stock Mailbag: Akebia, Neuralstem, Arrowhead
2015-08-13,FibroGen Announces Second Quarter 2015 Financial Results
2015-08-12,Nephrology Dialysis Transplantation Reports Phase 2 Data Of Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Shows Improved Hemoglobin Levels In Non-Dialysis CKD Subjects With Anemia
2015-08-10,FibroGen To Report Second Quarter 2015 Financial Results On August 13, 2015
2015-08-06,FibroGen Appoints Jeffrey W. Henderson To Board Of Directors
2015-07-27,FibroGen Receives FDA Clearance To Proceed With Clinical Study Of FG-3019 In Duchenne Muscular Dystrophy
2015-07-20,Analysts' Actions -- Amazon, Hertz and Kraft Heinz
2015-06-29,FibroGen Announces Receipt Of $120 Million License Payment From AstraZeneca
2015-06-12,5 Stocks Ready for Breakouts
2015-06-08,3 Stocks Rising on Unusual Volume
2015-06-01,FibroGen To Webcast Presentation At The Goldman Sachs Global Healthcare Conference
2015-05-12,FibroGen Announces First Quarter 2015 Financial Results
2015-05-07,FibroGen Announces Receipt Of Milestone Payment From AstraZeneca For Successful Completion Of Long-Term Pre-Clinical Safety Studies Of Roxadustat
2015-04-22,Oversold Conditions For FibroGen (FGEN)
2015-03-26,FibroGen Announces 2014 Financial Results And Provides Corporate Update
2015-03-19,FibroGen To Report Fourth Quarter And Full Year 2014 Financial Results On March 26, 2015
2015-03-06,5 Stocks Poised for Breakouts: Trevena, Inventergy and More
2014-11-17,FibroGen, Inc. Announces Full Exercise Of Greenshoe Option
,
,
,
